PRESS RELEASE

Q1 2023 — Press release

Q1 2023PDF · 8 pages322 KB
`
Media contact 	Investor contact
Timothy Barello, 212.299.2256 	Adam Minick, 312.340.8365
Laurie Bischel, 312.648.8698 	CME-G
news@cmegroup.com
www.cmegroup.com/media-
room.html
FOR IMMEDIATE RELEASE
CME Group Inc. Reports First-Quarter 2023 Financial Results
• 	Highest quarterly adjusted net income and adjusted earnings per share
ever
CHICAGO, April 26, 2023 - CME Group Inc. (NASDAQ: CME) today reported financial
results for the first quarter of 2023.
The company reported revenue of $1.4 billion and operating income of $914 million for
the first quarter of 2023. Net income was $884 million and diluted earnings per common share
were $2.43. On an adjusted basis, net income was $882 million and diluted earnings per
common share were $2.42. Financial results presented on an adjusted basis for the first quarter
of 2023 and 2022 exclude certain items, which are detailed in the reconciliation of non-GAAP
results. 1
"As global market participants sought to manage risk across asset classes, we saw a
flight to futures, resulting in our second-highest quarterly revenue, highest adjusted net income
and highest adjusted earnings per share ever,” said Terry Duffy, CME Group Chairman and
Chief Executive Officer. “During the quarter, our total daily volume surpassed 25 million
contracts 28 times, including a new single-day volume record of 66.3 million contracts on March
13. Of particular note was our double-digit growth in options and interest rate products, including
the growth in our SOFR derivatives complex, driven by ongoing Fed policy changes and
regional bank stress. Looking ahead, we expect risk management will continue to be more
important than ever, and we will remain focused on meeting our clients’ needs in this volatile
environment.”
1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of
GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation materials.
- more -

-- 1 of 8 --

`
Page 2
First-quarter 2023 average daily volume (ADV) was 26.9 million contracts. Non-U.S.
ADV reached 7.2 million contracts, which included the second-highest quarterly ADV across
EMEA, Asia and Latin America.
Clearing and transaction fees revenue for first-quarter 2023 totaled $1.2 billion. The total
average rate per contract was $0.664. Market data revenue totaled $166 million for first-quarter
2023.
As of March 31, 2023, the company had approximately $1.7 billion in cash (including
$100 million deposited with Fixed Income Clearing Corporation (FICC) and included in other
current assets) and $3.4 billion of debt. The company paid dividends of approximately $2.0
billion during the first quarter of 2023. The company has returned over $21.0 billion to
shareholders in the form of dividends since the implementation of the variable dividend policy in
early 2012.
CME Group will hold a Q&A conference call to discuss first-quarter 2023 results at
8:30 a.m. Eastern Time today. A live audio webcast of the Q&A call will be available on the
Investor Relations section of CME Group’s website at www.cmegroup.com. An archived
recording will be available for up to two months after the call.
As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients
to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data - empowering
market participants worldwide to efficiently manage risk and capture opportunities. CME Group
exchanges offer the widest range of global benchmark products across all major asset classes based on
interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company
offers futures and options on futures trading through the CME Globex® platform, fixed income trading via
BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's
leading central counterparty clearing providers, CME Clearing.
CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are
trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of
Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are
trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc.
BrokerTec and EBS are trademarks of BrokerTec Europe LTD and EBS Group LTD, respectively. The
S&P 500 Index is a product of S&P Dow Jones Indices LLC (“S&P DJI”). “S&P®”, “S&P 500®”, “SPY®”,
“SPX®”, US 500 and The 500 are trademarks of Standard & Poor’s Financial Services LLC; Dow Jones®,
DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark
Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc.
Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by
S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products.
All other trademarks are the property of their respective owners.
- more -

-- 2 of 8 --

`
Page 3
Statements in this press release that are not historical facts are forward-looking statements. These
statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are
difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied
in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking
statements. We want to caution you not to place undue reliance on any forward-looking statements. We undertake
no obligation to publicly update any forward-looking statements, whether as a result of new information, future
events or otherwise. Among the factors that might affect our performance are increasing competition by foreign
and domestic entities, including increased competition from new entrants into our markets and consolidation of
existing entities; our ability to keep pace with rapid technological developments, including our ability to complete
the development, implementation and maintenance of the enhanced functionality required by our customers while
maintaining reliability and ensuring that such technology is not vulnerable to security risks; our ability to continue
introducing competitive new products and services on a timely, cost-effective basis, including through our electronic
trading capabilities, and our ability to maintain the competitiveness of our existing products and services; our ability
to adjust our fixed costs and expenses if our revenues decline; our ability to maintain existing customers at
substantially similar trading levels, develop strategic relationships and attract new customers; our ability to expand
and globally offer our products and services; changes in regulations, including the impact of any changes in laws or
government policies with respect to our products or services or our industry, such as any changes to regulations and
policies that require increased financial and operational resources from us or our customers; the costs associated
with protecting our intellectual property rights and our ability to operate our business without violating the
intellectual property rights of others; decreases in revenue from our market data as a result of decreased demand
or changes to regulations in various jurisdictions; changes in our rate per contract due to shifts in the mix of the
products traded, the trading venue and the mix of customers (whether the customer receives member or non-
member fees or participates in one of our various incentive programs) and the impact of our tiered pricing
structure; the ability of our credit and liquidity risk management practices to adequately protect us from the credit
risks of clearing members and other counterparties, and to satisfy the margin and liquidity requirements associated
with the BrokerTec matched principal business; the ability of our compliance and risk management programs to
effectively monitor and manage our risks, including our ability to prevent errors and misconduct and protect our
infrastructure against security breaches and misappropriation of our intellectual property assets; our dependence
on third-party providers and exposure to risk through third parties, including risks related to the performance,
reliability and security of technology used by our third-party providers and third party providers that our clients rely
on; volatility in commodity, equity and fixed income prices, and price volatility of financial benchmarks and
instruments such as interest rates, credit spreads, equity indices, fixed income instruments and foreign exchange
rates; economic, social, political and market conditions, including the volatility of the capital and credit markets and
the impact of economic conditions on the trading activity of our current and potential customers; the impact of the
COVID-19 pandemic and response by governments and other third parties; our ability to accommodate increases in
contract volume and order transaction traffic and to implement enhancements without failure or degradation of
the performance of our trading and clearing systems; our ability to execute our growth strategy and maintain our
growth effectively; our ability to manage the risks, control the costs and achieve the synergies associated with our
strategy for acquisitions, investments and alliances, including those associated with the performance of our joint
ventures with S&P Dow Jones (S&P Dow Jones Indices LLC) in index services and in trade processing/post trade
services (OSTTRA), our primary data distribution partners’ actions and our partnership with Google Cloud; variances
in earnings on cash accounts and collateral that our clearing house holds for its clients; impact of CME Group
pricing and incentive changes; impact of aggregation services and internalization on trade flow and volumes; any
negative financial impacts from changes to the terms of intellectual property and index rights; uncertainty related
to the adoption and growth of SOFR and its impact on our business; our ability to continue to generate funds and/or

-- 3 of 8 --

`
manage our indebtedness to allow us to continue to invest in our business; industry, channel partner and customer
consolidation; decreases in trading and clearing activity; the imposition of a transaction tax or user fee on futures
and options transactions and/or repeal of the 60/40 tax treatment of such transactions; our ability to maintain our
brand and reputation; and the unfavorable resolution of material legal proceedings. For a detailed discussion and
additional information concerning these and other factors that might affect our performance, see our other recent
periodic filings, including our Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the
Securities and Exchange Commission ("SEC") on February 27, 2023, under the caption "Risk Factors".
# # #

-- 4 of 8 --

`
CME Group Inc. and Subsidiaries
Consolidated Balance Sheets
(in millions)
March 31, 2023 	December 31, 2022
ASSETS
Current Assets:
Cash and cash equivalents 	$ 	1,565.2 	$ 	2,720.1
Marketable securities 	105.0 	96.0
Accounts receivable, net of allowance 	723.6 	483.2
Other current assets (includes $5.1 and $4.9 in restricted cash) 	547.2 	529.8
Performance bonds and guaranty fund contributions 	128,090.7 	135,249.2
Total current assets 	131,031.7 	139,078.3
Property, net of accumulated depreciation and amortization 	440.3 	455.5
Intangible assets—trading products 	17,175.3 	17,175.3
Intangible assets—other, net 	3,217.4 	3,269.7
Goodwill 	10,490.5 	10,482.5
Other assets (includes $0.0 and $0.1 in restricted cash) 	3,684.0 	3,714.4
Total Assets 	$ 	166,039.2 	$ 	174,175.7
LIABILITIES AND EQUITY
Current Liabilities:
Accounts payable 	$ 	97.2 	$ 	121.4
Short-term debt 	16.3 	16.0
Other current liabilities 	839.7 	2,300.9
Performance bonds and guaranty fund contributions 	128,090.7 	135,249.2
Total current liabilities 	129,043.9 	137,687.5
Long-term debt 	3,423.1 	3,422.4
Deferred income tax liabilities, net 	5,356.8 	5,361.1
Other liabilities 	831.0 	826.0
Total Liabilities 	138,654.8 	147,297.0
Total CME Group Shareholders’ Equity 	27,384.4 	26,878.7
Total Liabilities and Equity 	$ 	166,039.2 	$ 	174,175.7

-- 5 of 8 --

`
CME Group Inc. and Subsidiaries
Consolidated Statements of Income
(dollars in millions, except per share amounts; shares in thousands)
Quarter Ended
March 31,
2023 	2022
Revenues
Clearing and transaction fees 	$ 	1,200.2 	$ 	1,138.1
Market data and information services 	165.8 	151.7
Other 	75.6 	56.8
Total Revenues 	1,441.6 	1,346.6
Expenses
Compensation and benefits 	204.5 	185.2
Technology 	51.3 	45.9
Professional fees and outside services 	38.3 	31.8
Amortization of purchased intangibles 	56.8 	58.4
Depreciation and amortization 	31.9 	33.5
Licensing and other fee agreements 	84.7 	80.9
Other 	60.4 	51.8
Total Expenses 	527.9 	487.5
Operating Income 	913.7 	859.1
Non-Operating Income (Expense)
Investment income 	1,357.7 	73.1
Interest and other borrowing costs 	(39.9) 	(42.5)
Equity in net earnings of unconsolidated subsidiaries 	78.2 	73.3
Other non-operating income (expense) 	(1,152.8) 	(46.7)
Total Non-Operating Income (Expense) 	243.2 	57.2
Income before Income Taxes 	1,156.9 	916.3
Income tax provision 	273.1 	205.3
Net Income 	$ 	883.8 	$ 	711.0
Net Income Attributable to Common Shareholders of CME Group 	$ 	872.7 	$ 	702.0
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic 	$ 	2.43 	$ 	1.96
Diluted 	2.43 	1.95
Weighted Average Number of Common Shares:
Basic 	358,933 	358,609
Diluted 	359,313 	359,180

-- 6 of 8 --

`
CME Group Inc. and Subsidiaries
Quarterly Operating Statistics
1Q 2022 	2Q 2022 	3Q 2022 	4Q 2022 	1Q 2023
Trading Days 	62 	62 	64 	63 	62
Quarterly Average Daily Volume (ADV)(1)
CME Group ADV (in thousands)
Product Line 	1Q 2022 	2Q 2022 	3Q 2022 	4Q 2022 	1Q 2023
Interest rates 	12,484 	10,630 	10,357 	9,832 	14,490
Equity indexes 	7,950 	7,751 	7,445 	7,465 	7,303
Foreign exchange 	904 	950 	1,091 	1,000 	969
Energy 	2,515 	1,932 	1,837 	1,829 	2,083
Agricultural commodities 	1,474 	1,308 	1,208 	1,171 	1,379
Metals 	593 	484 	498 	508 	649
Total 	25,920 	23,055 	22,437 	21,803 	26,873
Venue
CME Globex 	24,060 	21,531 	21,021 	20,279 	24,171
Open outcry 	1,030 	725 	704 	746 	1,623
Privately negotiated 	830 	799 	711 	778 	1,080
Total 	25,920 	23,055 	22,437 	21,803 	26,873
Quarterly Average Rate Per Contract (RPC)(1)
CME Group RPC
Product Line 	1Q 2022 	2Q 2022 	3Q 2022 	4Q 2022 	1Q 2023
Interest rates 	$ 	0.484 	$ 	0.493 	$ 	0.479 	$ 	0.500 	$ 	0.495
Equity indexes 	0.526 	0.532 	0.524 	0.535 	0.595
Foreign exchange 	0.800 	0.767 	0.729 	0.756 	0.790
Energy 	1.124 	1.171 	1.140 	1.181 	1.300
Agricultural commodities 	1.378 	1.411 	1.351 	1.356 	1.349
Metals 	1.482 	1.506 	1.520 	1.519 	1.517
Average RPC 	$ 	0.644 	$ 	0.647 	$ 	0.631 	$ 	0.651 	$ 	0.664
1. ADV and RPC includes futures and options on futures only.

-- 7 of 8 --

`
CME Group Inc. and Subsidiaries
Reconciliation of GAAP to non-GAAP Measures
(dollars in millions, except per share amounts; shares in thousands)
Quarter Ended
March 31,
2023 	2022
Net Income 	$ 	883.8 	$ 	711.0
Restructuring and severance 	0.7 	3.7
Amortization of purchased intangibles(1) 	70.1 	69.8
Strategic transaction-related costs (credits) (2) 	(2.2) 	1.6
Foreign exchange transaction (gains) losses 	0.7 	(4.3)
Unrealized and realized (gains) losses on investments 	(74.8) 	(4.0)
Debt costs related to refinancing 	— 	7.7
Trading floor enhancements 	— 	4.4
Income tax effect related to above 	4.0 	(15.8)
Other income tax items 	— 	(7.9)
Adjusted Net Income 	$ 	882.3 	$ 	766.2
Adjusted Net Income Attributable to Common Shareholders of CME Group 	$ 	871.1 	$ 	756.6
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic 	$ 	2.43 	$ 	1.96
Diluted 	2.43 	1.95
Adjusted Earnings per Share Attributable to Common Shareholders of CME Group:
Basic 	$ 	2.43 	$ 	2.11
Diluted 	2.42 	2.11
Weighted Average Number of Common Shares:
Basic 	358,933 	358,609
Diluted 	359,313 	359,180
Preferred shares(3) 	4,584 	4,584
1. Includes $10.9 million of amortization of purchased intangibles (net of tax) at OSTTRA and $2.5 million of
amortization of purchased intangibles at S&P Dow Jones Indices LLC, reported in Equity in net earnings of
unconsolidated subsidiaries on the Consolidated Statements of Income.
2. Strategic transaction-related costs (credits) primarily include items related to the NEX transaction and the
formation of the OSTTRA joint venture.
3. Preferred shares have similar rights as common shares without voting rights.
23-37

-- 8 of 8 --